Alector Inc (ALEC)
5.35
+0.33
(+6.57%)
USD |
NASDAQ |
Nov 04, 12:55
Alector Revenue (Quarterly): 15.08M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 15.08M |
March 31, 2024 | 15.89M |
December 31, 2023 | 15.19M |
September 30, 2023 | 9.109M |
June 30, 2023 | 56.21M |
March 31, 2023 | 16.55M |
December 31, 2022 | 14.44M |
September 30, 2022 | 14.85M |
June 30, 2022 | 79.85M |
March 31, 2022 | 24.47M |
December 31, 2021 | 13.99M |
September 30, 2021 | 182.41M |
June 30, 2021 | 6.568M |
March 31, 2021 | 4.11M |
Date | Value |
---|---|
December 31, 2020 | 4.853M |
September 30, 2020 | 5.904M |
June 30, 2020 | 3.17M |
March 31, 2020 | 7.171M |
December 31, 2019 | 6.001M |
September 30, 2019 | 2.696M |
June 30, 2019 | 6.917M |
March 31, 2019 | 5.605M |
December 31, 2018 | 9.145M |
September 30, 2018 | 6.503M |
June 30, 2018 | 7.109M |
March 31, 2018 | 4.92M |
December 31, 2017 | 3.059M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
3.17M
Minimum
Jun 2020
182.41M
Maximum
Sep 2021
26.10M
Average
14.44M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
Omeros Corp | -- |
Nuwellis Inc | 2.194M |
Harrow Inc | 48.94M |
Amphastar Pharmaceuticals Inc | 182.39M |
PetIQ Inc | 328.94M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -38.68M |
Total Expenses (Quarterly) | 60.69M |
EPS Diluted (Quarterly) | -0.40 |
Enterprise Value | -14.78M |
Profit Margin (Quarterly) | -256.4% |
Earnings Yield | -33.64% |
Normalized Earnings Yield | -33.64 |